Will 2024 Be a Prosperous Year for China?

 | Jan 08, 2024 03:12AM ET

After a period of strong gains and a close of the year near all-time highs, markets now seem to be facing a more tense climate with profit-taking on the world's major stock exchanges. Volatility has again become a major factor, with investors becoming more cautious and uncertain about possible interest rate cuts.

For our weekly appointment, we will focus on the most interesting stocks and futures contracts of the moment, as well as examine the general macroeconomic situation in the markets. 

The stock of Moderna Inc (NASDAQ:MRNA) has been performing excellently in the stock market. During the last session, Oppenheimer increased his recommendation from "market performance" to "outperformance." According to the analyst responsible for the stock, there will be numerous catalysts in the next two years that will drive the lab's growth. Moderna is expected to have as many as five products on the market by 2026.